Experimental combo targets tough breast cancer
Disease control
Terminated
This study tested whether combining two drugs, ZEN003694 and talazoparib, could help control triple-negative breast cancer in patients whose cancer had progressed despite prior treatments. The trial involved 115 adults with advanced disease who had not responded to previous thera…
Phase: PHASE2 • Sponsor: Zenith Epigenetics • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC